Fuisz Technologies Introduces Two New Drug Dosage Formats.CHANTILLY, Va.--(HealthWire)--May 2, 1996--Fuisz Technologies Ltd. (Nasdaq-NMS: FUSE) today announced the availability of two new drug dosage formats based on its proprietary microsphere Not to be confused with Glass microphere. This article largely refers to micropheres or protein protocells as small spherical units postulated by some scientists as a key stage in the origin of life. technology. One of the new formats, Spoon Dose(TM), is an entirely new method of oral drug delivery that replaces tablet formats. Spoon Dose(TM) utilizes Fuisz Technologies' proprietary microsphere technology to package drug dosages into extremely small beads that are coated to mask taste, and respond to the normal swallowing reflex swal·low·ing reflex n. Swallowing caused by stimulation of the palate, fauces, or posterior pharyngeal wall. Also called pharyngeal reflex. when taken with or without water. "Spoon Dose(TM) is a radically new format that is perhaps the most economical drug delivery technique," said Richard C. Fuisz, M.D., Chairman and Chief Executive Officer of Fuisz Technologies. "This new format will have wide application in both the over-the-counter and prescription drug prescription drug Prescription medication Pharmacology An FDA-approved drug which must, by federal law or regulation, be dispensed only pursuant to a prescription–eg, finished dose form and active ingredients subject to the provisos of the Federal Food, Drug, markets." Fuisz also announced the availability of its microsphere technology for use in dry compaction, a potentially widely-usable tablet formulation technique. "Our microsphere technology applied to dry compaction can allow for significant savings in OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). and prescription tablet manufacturing processes by eliminating the costly and time-intensive wet granulation granulation /gran·u·la·tion/ (-shun) 1. the division of a hard substance into small particles. 2. the formation in wounds of small, rounded masses of tissue during healing; also the mass so formed. step," said Dr. Fuisz. "We believe this technology has the potential to revolutionize standard tablet manufacturing techniques." The Company reported that it is in active negotiations with several clients to develop products using both applications. Fuisz Technologies Ltd. is engaged in the development and commercialization of a wide range of oral drug delivery and food applications. CONTACT: Fuisz Technologies Ltd. Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Richard C. Fuisz, M.D. 703/803-3260 or Burns McClellan James Heins (media) or Susan Burnett (investors) 212/505-1919 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion